Abstract Pleuroparenchymal fibroelastosis (PPFE) is an uncommon but serious late pulmonary complication after hematopoietic stem cell transplantation (HSCT), frequently resulting in the need for lung transplantation and contributing substantially to mortality. However, its risk factors and prediagnostic pulmonary function trajectory remain poorly defined. This multicenter retrospective cohort study included 1818 patients who underwent allogeneic HSCT between 2005 and 2023.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yuta
Contact Yuta, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack